We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+6.16%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$25B
AUM Growth
+$2.37B
(+11%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
4.67%
Top 10 Holdings %
Top 10 Hldgs %
16.34%
Holding
2,152
New
227
Increased
430
Reduced
632
Closed
714
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$783M |
| 2 |
Genuine Parts
GPC
|
+$573M |
| 3 |
Paychex
PAYX
|
+$431M |
| 4 |
Monster Beverage
MNST
|
+$119M |
| 5 |
Northern Trust
NTRS
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$804M |
| 2 |
Accenture
ACN
|
+$118M |
| 3 |
Sysco
SYY
|
+$76.9M |
| 4 |
Apple
AAPL
|
+$76.7M |
| 5 |
NetApp
NTAP
|
+$69.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.58% |
| 2 | Healthcare | 13.03% |
| 3 | Financials | 12.46% |
| 4 | Consumer Discretionary | 10.73% |
| 5 | Industrials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
iShares China Large-Cap ETF
FXI
$4.22B
| $577K | ﹤0.01% |
+13,492
| New | +$571K |
|
752
Teladoc Health
TDOC
$1.61B
| $577K | ﹤0.01% |
6,699
+3,802
| +131% | +$271K |
|
|
BCPC
753
Balchem Corp
BCPC
$5.29B
| $570K | ﹤0.01% |
5,090
+11
| +0.2% | +$1.16K |
|
754
Exponent
EXPO
$3.04B
| $569K | ﹤0.01% |
10,629
-1,049
| -9% | -$53.7K |
|
755
Keysight
KEYS
$53.6B
| $562K | ﹤0.01% |
8,504
+6
| +0.1% | +$372 |
|
|
CVIA
756
DELISTED
Covia Holdings Corporation Common Stock
CVIA
| $562K | ﹤0.01% |
62,804
| – | – |
|
|
LSXMK
757
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $556K | ﹤0.01% |
+16,827
| New | +$597K |
|
758
Dorman Products
DORM
$4.08B
| $555K | ﹤0.01% |
7,232
+980
| +16% | +$74.9K |
|
759
Gentex
GNTX
$4.88B
| $555K | ﹤0.01% |
25,865
-958,003
| -97% | -$22.2M |
|
760
Xtrackers MSCI Europe Hedged Equity ETF
DBEU
$767M
| $552K | ﹤0.01% |
19,322
| – | – |
|
761
Equinix
EQIX
$103B
| $550K | ﹤0.01% |
1,271
-6
| -0.5% | -$2.63K |
|
762
Manhattan Associates
MANH
$9.42B
| $540K | ﹤0.01% |
9,894
| – | – |
|
|
ASXC
763
DELISTED
Asensus Surgical, Inc.
ASXC
| $540K | ﹤0.01% |
+7,172
| New | +$485K |
|
764
Mine Safety
MSA
$6.78B
| $528K | ﹤0.01% |
4,964
-316
| -6% | -$31.9K |
|
765
Xcel Energy
XEL
$50.4B
| $526K | ﹤0.01% |
11,174
-6,878
| -38% | -$325K |
|
|
MANT
766
DELISTED
Mantech International Corp
MANT
| $526K | ﹤0.01% |
8,318
+75
| +0.9% | +$4.67K |
|
767
Chipotle Mexican Grill
CMG
$42.6B
| $522K | ﹤0.01% |
57,500
| – | – |
|
|
SHPG
768
DELISTED
Shire pic
SHPG
| $520K | ﹤0.01% |
2,875
-375
| -12% | -$64.9K |
|
769
Avanos Medical
AVNS
$1.17B
| $518K | ﹤0.01% |
7,575
+2,519
| +50% | +$162K |
|
770
Blackbaud
BLKB
$1.59B
| $518K | ﹤0.01% |
5,108
+648
| +15% | +$67.7K |
|
771
Bank of Hawaii
BOH
$3.17B
| $512K | ﹤0.01% |
6,500
-824
| -11% | -$68.3K |
|
772
C.H. Robinson
CHRW
$20.6B
| $511K | ﹤0.01% |
5,224
-298
| -5% | -$28K |
|
|
IFX
773
DELISTED
INFINEON TECH AG ADS(REP1 ORD)
IFX
| $505K | ﹤0.01% |
22,226
-916
| -4% | -$20.8K |
|
774
BWX Technologies
BWXT
$16.2B
| $501K | ﹤0.01% |
8,040
+102
| +1% | +$6.46K |
|
775
Cullen/Frost Bankers
CFR
$10.3B
| $499K | ﹤0.01% |
4,788
-6,386
| -57% | -$709K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2018 Portfolio in Review
As of Q3 2018, Glenmede Trust held 2,152 positions worth $25B, up 11% from $22.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Glenmede Trust deployed $1.17B of net new capital in Q3 2018, opening 227 new positions and adding to 430 existing holdings. Its largest new stake was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $804M trimmed.
- Glenmede Trust's largest Q3 2018 buy was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
- Glenmede Trust added most to Alphabet (Google) Class A in Q3 2018, an estimated $783M increase.
- Glenmede Trust's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $804M.
- Glenmede Trust fully exited BioTelemetry, Inc. in Q3 2018, selling an estimated $43.4M.
- Glenmede Trust's ten largest holdings make up 16% of its $25B portfolio in Q3 2018.
- Glenmede Trust opened 227 new positions and closed 714 in Q3 2018.
- Glenmede Trust's portfolio value rose 11% quarter-over-quarter to $25B.
Based on Glenmede Trust's 13F filing for Q3 2018, filed 15 Nov 2018.